On this page you will find experience reports sorted by drug groups, classes:
A
- ACE inhibitors
- Acid related disorders drugs
- Addictive disorders drugs
- Adrenergic and dopaminergic agents
- Adrenergics
- Alpha-adrenoreceptor antagonists
- Amines
- Amino acids
- Aminoquinolines
- Analgesics
- Anaplastic lymphoma kinase (ALK) inhibitors
- Anesthetics
- Angiotensin II receptor blockers (ARBs)
- Anti-acne preparations
- Anti-androgens
- Anti-dementia drugs
- Anti-estrogens
- Antibacterials
- Antibiotics
- Antibiotics and chemotherapeutics for dermatological use
- Anticholinergic agents
- Anticholinergics
- Anticholinesterases
- Antidepressants
- Antidiarrheals
- Antiemetics
- Antiepileptics
- Antifibrinolytics
- Antifungals
- Antiglaucoma preparations and miotics
- Antigout preparations
- Antihemorrhagics
- Antihistamines
- Antihypertensives
- Antiinfectives
- Antiinflammatory agents
- Antiinflammatory and antirheumatic products
- Antimalarials
- Antimetabolites
- Antimigraine preparations
- Antimycotics
- Antineovascularisation agents
- Antiobesity preparations
- Antiparkinson drugs
- Antiprotozoals
- Antipruritics
- Antipsychotics
- Antithrombotic agents
- Antivirals
- Anxiolytics
- Aromatase inhibitors
B
- Benign prostatic hypertrophy drugs
- Benzamides
- Benzodiazepine
- Beta blocking agents
- Beta-lactam antibacterials
- Biguanides
- Blood glucose lowering drugs
- Bone diseases
- Bruton’s tyrosine kinase (BTK) inhibitors
C
- Calcineurin inhibitors
- Calcium channel blockers
- Calcium homeostasis
- Carbamic acid esters
- Cardiac stimulants
- Cardiac therapy
- CD20 (Clusters of Differentiation 20) inhibitors
- CD38 (Clusters of Differentiation 38) inhibitors
- Cephalosporins
- Chemotherapeutics
- Constipation drugs
- Contraceptives
- Corticosteroids
- Cough and cold preparations
- Coxibs
- Cyclin-dependent kinase (CDK) inhibitors
D
- Decongestants
- Dermatitis agents
- Diabetes drugs
- Diazepines
- Dihydroorotate dehydrogenase (DHODH) inhibitors
- Diphenylmethane derivatives
- Direct factor Xa inhibitors
- Direct thrombin inhibitors
- Diuretics
E
- Endocrine therapy
- Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
- Erectile dysfunction drugs
F
G
- Gabapentinoids
- Glucagon-like peptide-1 (GLP-1) analogues
- Glucocorticoids
- Gonadotropin releasing hormone
- Gonadotropins and other ovulation stimulants
- Gynecologicals
H
- HCV infections antivirals
- Hemorrhoids and anal fissures drugs
- HIV infections antivirals
- HMG CoA reductase inhibitors
- Hormonal contraceptives
- Hormone antagonists
- Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors
- Hyperkalemia and hyperphosphatemia drugs
- Hypnotics and sedatives
I
- Imidazole and triazole derivatives
- Immunosuppressants
- Indole derivatives
- Insulins
- Interleukin inhibitors
J
L
M
- Macrolides
- Monoamine oxidase B inhibitors
- Monoamine oxidase inhibitors
- Monoclonal antibodies
- Muscle relaxants
N
O
- Obstructive airway diseases drugs
- Ophthalmologicals
- Opioid dependence drugs
- Opioids
- Opium alkaloids and derivatives
- Other antineoplastic agents
- Otologicals
- Ovulation stimulants
- Oxazepines
P
- Papillomavirus vaccines
- Parathyroid hormones
- PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors
- Penicillins
- Peptic ulcer and gastro-oesophageal reflux disease (GORD)
- Peripheral opioid receptor antagonists
- Phenylalkylamine
- Phosphatidylinositol-3-kinase (Pi3K) inhibitors
- Piperazine derivatives
- Plant alkaloids and other natural products
- Platelet aggregation inhibitors
- Poly (ADP-ribose) polymerase (PARP) inhibitors
- Progestogens
- Prostaglandins
- Protein kinase inhibitors
- Proton pump inhibitors
- Psychostimulants
S
- Selective beta-2-adrenoreceptor agonists
- Selective serotonin reuptake inhibitors
- Sex hormones and modulators of the genital system
- Sodium-glucose co-transporter 2 (SGLT2) inhibitors
- Sphingosine-1-phosphate (S1P) receptor modulators
- Stomatological preparations
- Sulfonamides
T
- Taxanes
- Tetracyclines
- Thiazepines and oxepines
- Thioxanthene derivatives
- Topoisomerase 1 (TOP1) inhibitors
- Triazole and tetrazole derivatives
- Tumor necrosis factor alpha (TNF-a) inhibitors